Mary DiBiase insider trades
Open-market stock purchases and sales by Mary DiBiase, Chief Operating Officer at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 8, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- XFOR X4 Pharmaceuticals, Inc: 17 sales, last Feb 12, 2025